# Safety and Effectiveness of a Seasonal Live Attenuated Influenza Vaccine in a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like Virus

> **NCT02950688** · PHASE1 · WITHDRAWN · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- Influenza, Human

## Interventions

- **BIOLOGICAL:** Seasonal LAIV
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** Wild-type A/California/2009-like Influenza Virus

## Key facts

- **NCT ID:** NCT02950688
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** 2020-12
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2017-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02950688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02950688, "Safety and Effectiveness of a Seasonal Live Attenuated Influenza Vaccine in a Human Challenge Model of Infection With Wild-type (wt) Influenza A/California/2009 (H1N1)-Like Virus". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT02950688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*